Emery Rebecca L, Levine Michele D
Department of Psychology, University of Pittsburgh, Pittsburgh, PA;
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA.
Nicotine Tob Res. 2016 May;18(5):966-70. doi: 10.1093/ntr/ntv196. Epub 2015 Sep 18.
Although expired-air carbon monoxide (CO) is a well characterized biomarker of cigarette smoking, limited research has assessed whether the standard clinical CO cutoffs need to be altered for postpartum women and whether these cutoffs remain constant across the postpartum year. Accordingly, the present study evaluated the effectiveness of using CO as a method to confirm smoking status relative to salivary cotinine among postpartum women and assessed optimal CO criteria to confirm smoking status across the postpartum year. Differences in optimal CO criteria to confirm smoking status also were examined between black and white postpartum women.
Women (N = 208) for the present study had quit smoking for their current pregnancy and were enrolled in a larger postpartum relapse prevention intervention. Smoking status was assessed at 12, 24, and 52 weeks postpartum using both expired-air CO and salivary cotinine.
Receiver-operating characteristic analyses indicated that CO provided moderately high diagnostic accuracy to distinguish between women who were and were not smoking when using salivary cotinine as the reference criterion to confirm smoking status. CO cutoffs of 2 and 3 parts per million (ppm) had the highest overall efficiency and combined sensitivity and specificity across the postpartum year. Results were consistent for black and white women.
These findings indicate that optimal CO criteria to confirm smoking status remains stable throughout the postpartum year and support a need to utilize CO cutoffs much lower than the standard clinical CO criterion of 8 ppm to confirm abstinence among postpartum women.
Findings from the present study confirm the value of CO as a biomarker of smoking status among postpartum women. Results indicate that CO cutoffs of 2 and 3 ppm were optimal for confirming smoking status across the entire postpartum year in both black and white women. These findings offer a replication and extension of previous work and indicate that optimal CO criteria to confirm smoking status remain stable throughout the postpartum period and further support a need to utilize CO cutoffs much lower than the standard clinical criterion of 8 ppm to confirm smoking status among postpartum women.
尽管呼出气一氧化碳(CO)是吸烟的一种特征明确的生物标志物,但仅有有限的研究评估了产后女性的标准临床CO临界值是否需要调整,以及这些临界值在产后一年内是否保持不变。因此,本研究评估了使用CO作为确认产后女性吸烟状况的方法相对于唾液可替宁的有效性,并评估了在产后一年内确认吸烟状况的最佳CO标准。还比较了黑人和白人产后女性在确认吸烟状况的最佳CO标准上的差异。
本研究中的女性(N = 208)在本次怀孕时已戒烟,并参加了一项更大规模的产后预防复吸干预研究。在产后12周、24周和52周时,使用呼出气CO和唾液可替宁评估吸烟状况。
受试者工作特征分析表明,以唾液可替宁作为确认吸烟状况的参考标准时,CO在区分吸烟和不吸烟女性方面具有中等偏高的诊断准确性。百万分之2和3(ppm)的CO临界值在产后一年内具有最高的总体效率以及综合敏感性和特异性。黑人和白人女性的结果一致。
这些发现表明,确认吸烟状况的最佳CO标准在整个产后一年内保持稳定,并支持需要使用远低于8 ppm的标准临床CO临界值来确认产后女性的戒烟情况。
本研究结果证实了CO作为产后女性吸烟状况生物标志物的价值。结果表明,百万分之2和3 ppm的CO临界值在整个产后一年内对于确认黑人和白人女性的吸烟状况都是最佳的。这些发现重复并扩展了先前的研究工作,表明确认吸烟状况的最佳CO标准在整个产后期间保持稳定,并进一步支持需要使用远低于8 ppm的标准临床临界值来确认产后女性的吸烟状况。